amol athawale people page on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
People Landing|14 matching stories

amol athawale News, Mentions & Market Context

AI-analyzed market coverage and mentions for amol athawale, including related stories and trading context.

What Traders Do Next

amol athawale is more useful with a process around it.

Use these pages to understand the story first. Execution usually comes later, after the idea is filtered, tested, and sized correctly.

This is here if you want to go deeper, not as a push.Explore Anadi
Look for entry points in HDFCLIFE and ONGC, potentially targeting short-term gains.|Quick check: HDFCLIFE neutral (-1.1% 1d), ONGC neutral (+0.7% 1d).

Latest amol athawale Mentions

Look for entry points in SBICARD and DLF, respecting technical levels and risk management.|Quick check: SBICARD bullish bias (+1.3% 1d), DLF bullish bias (overbought).
Consider a 'buy on dips' strategy for pharma companies with strong backward integration or diversified sourcing, but with strict stop-losses due to input cost volatility.|Quick check: SUNPHARMA bearish bias (+0.0% 1d), AUROPHARMA bullish bias (-1.4% 1d).
Consider long positions in TECHM and MARUTI with defined targets and stop-losses.|Quick check: TECHM bullish bias (+0.0% 1d), MARUTI bullish bias (+0.0% 1d).
Market has likely priced in the headline, so trade GRANULES only on confirmation of clean follow-up with upside limited to verified US export normalization; otherwise stay underweight and use defensive risk discipline.
Given the age of the article, re-evaluate the technical charts of JSW Steel and TVS Motor Company for current short-term momentum and entry points, while Swiggy remains a pre-IPO prospect.
Given the article's age, traders should use these recommendations as a starting point for their own technical analysis, verifying current price action and market conditions before considering any trades.
Given the article's age, the market has likely priced in some of this, but monitor Q4 and Q1 results of API manufacturers for sustained margin pressure; consider short-term bearish bias on API-heavy pharma stocks.
Consider short-term long positions in recommended stocks like Titan and GMR Airports, but be mindful of the article's age and potential market pricing.
Bearish for Indian pharma; consider short-term downside risk for companies heavily reliant on propane for API/formulation manufacturing.
Focus on the specific stocks recommended by Kotak Securities for short-term tactical plays, but be mindful of the broader market crash context.